Pembrolizumab — Dosing in CKD & Dialysis

Pembrolizumab (Immunotherapy): renal dosing adjustments, dialyzability (Not studied in the label (no statement on removal by dialysis); humanized IgG4 kappa monoclonal antibody of about 149 kDa (Keytruda label 11). Level estimated from molecule size or protein binding; not measured.), and renal-rele

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.